Please note: this guideline has exceeded its review date and is currently under review by specialists. Exercise caution in the use of the clinical guideline.
This guideline covers thromboprophylaxis specifically in the non-pregnant COVID-19 population. Seek specialist obstetric advice for thromboprophylaxis in pregnant women with suspected or confirmed COVID-19 infection.
For guidance on thromboprophylaxis in patients who are either not suspected of having COVID-19 or are not confirmed COVID-19 positive, see the main Thromboprophylaxis guideline.
Patients with COVID-19 are at high risk of developing a venous thromboembolism (VTE) and it is essential that effective thromboprophylaxis is considered for all patients admitted to hospital with suspected or confirmed COVID-19 infection. Using thromboprophylaxis in patients with COVID-19 will likely save lives.
Thromboprophylaxis management in COVID patients differs depending on whether a patient is being treated within a critical care area (intensive care unit, high dependency unit) or a non-critical care area.
There are two guidelines to consider, depending on whether the patient is on renal replacement therapy or not. Refer to:
Note: The above documents contain some links to NHSAAA AthenA that are only active if accessing via NHS network.
Refer to the main Thromboprophylaxis guideline.
Page last updated September 2022.